Egon Stenager

10.5k total citations
196 papers, 6.8k citations indexed

About

Egon Stenager is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Egon Stenager has authored 196 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Pathology and Forensic Medicine, 39 papers in Psychiatry and Mental health and 33 papers in Neurology. Recurrent topics in Egon Stenager's work include Multiple Sclerosis Research Studies (120 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (26 papers) and Systemic Sclerosis and Related Diseases (20 papers). Egon Stenager is often cited by papers focused on Multiple Sclerosis Research Studies (120 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (26 papers) and Systemic Sclerosis and Related Diseases (20 papers). Egon Stenager collaborates with scholars based in Denmark, United States and Sweden. Egon Stenager's co-authors include Ulrik Dalgas, Thorsten Ingemann-Hansen, Henrik Brønnum‐Hansen, Thor Petersen, Kenneth B. Jensen, Nils Koch‐Henriksen, N. Koch–Henriksen, L Knudsen, Kirsten Ohm Kyvik and Bjarne Laursen and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Egon Stenager

188 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egon Stenager Denmark 46 4.7k 1.7k 1.5k 1.0k 929 196 6.8k
Christoph Heesen Germany 51 5.0k 1.1× 1.5k 0.9× 1.4k 1.0× 902 0.9× 610 0.7× 275 8.6k
Francesco Patti Italy 49 6.3k 1.3× 2.8k 1.6× 1.2k 0.8× 724 0.7× 1.1k 1.2× 332 9.7k
Nicholas G. LaRocca United States 36 5.4k 1.1× 1.4k 0.8× 1.5k 1.1× 698 0.7× 760 0.8× 73 7.0k
Timothy Vollmer United States 47 5.4k 1.1× 1.8k 1.0× 776 0.5× 683 0.7× 1.0k 1.1× 125 8.0k
Bruno Brochet France 50 5.4k 1.1× 2.4k 1.3× 903 0.6× 268 0.3× 1.1k 1.2× 180 9.4k
Ulrik Dalgas Denmark 51 4.6k 1.0× 1.3k 0.7× 2.0k 1.4× 1.9k 1.8× 586 0.6× 208 7.7k
Basil Sharrack United Kingdom 40 2.1k 0.5× 1.5k 0.8× 600 0.4× 470 0.5× 405 0.4× 165 5.8k
Maria Giovanna Marrosu Italy 45 3.0k 0.6× 1.5k 0.9× 501 0.3× 394 0.4× 867 0.9× 248 6.7k
Harald Nyland Norway 45 3.4k 0.7× 1.6k 0.9× 804 0.6× 204 0.2× 937 1.0× 172 6.5k
S. Fredrikson Sweden 45 4.2k 0.9× 1.8k 1.0× 477 0.3× 366 0.4× 1.0k 1.1× 198 7.5k

Countries citing papers authored by Egon Stenager

Since Specialization
Citations

This map shows the geographic impact of Egon Stenager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egon Stenager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egon Stenager more than expected).

Fields of papers citing papers by Egon Stenager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egon Stenager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egon Stenager. The network helps show where Egon Stenager may publish in the future.

Co-authorship network of co-authors of Egon Stenager

This figure shows the co-authorship network connecting the top 25 collaborators of Egon Stenager. A scholar is included among the top collaborators of Egon Stenager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egon Stenager. Egon Stenager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merki‐Feld, Gabriele S., Riley Bove, Lisa B. Haddad, et al.. (2024). Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning. The European Journal of Contraception & Reproductive Health Care. 30(2). 59–73.
2.
Stenager, Egon, et al.. (2023). Multiple Sclerosis and Suicide Attempts: A Review including a Meta-Analysis of Prevalence. Acta Neurologica Scandinavica. 2023. 1–11. 2 indexed citations
3.
Jølving, Line Riis, et al.. (2023). Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review. Clinical Epidemiology. Volume 15. 375–389. 5 indexed citations
5.
Schmidt, Marianne, et al.. (2021). The lived experience of uncertainty in everyday life with MS. Disability and Rehabilitation. 44(20). 5957–5963. 10 indexed citations
6.
Riemenschneider, Morten, Lars G. Hvid, Steffen Ringgaard, et al.. (2021). Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open. 11(1). e043699–e043699. 15 indexed citations
7.
Koch‐Henriksen, Nils, Lau Caspar Thygesen, Egon Stenager, Bjarne Laursen, & Melinda Magyari. (2018). Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology. 90(22). e1954–e1963. 130 indexed citations
8.
Binzer, Michael, et al.. (2015). Hver femte tilfælde af multipel sklerose anses for arveligt. Ugeskrift for Læger. 176. 2–5. 1 indexed citations
9.
Asgari, Nasrin, Anne Voss, Troels Steenstrup, et al.. (2013). Interferon Alpha Association with Neuromyelitis Optica. SHILAP Revista de lepidopterología. 2013. 1–6. 17 indexed citations
10.
Nielsen, Nete Munk, Kristian Tore Jørgensen, Peter Bager, et al.. (2013). Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis. American Journal of Epidemiology. 177(11). 1289–1295. 34 indexed citations
11.
Nielsen, Nete Munk, Kristian Tore Jørgensen, Egon Stenager, et al.. (2011). Reproductive History and Risk of Multiple Sclerosis. Epidemiology. 22(4). 546–552. 60 indexed citations
12.
Bentzen, Joan, Lau Caspar Thygesen, Esben Meulengracht Flachs, et al.. (2010). Diagnostic delay in multiple sclerosis. Multiple Sclerosis Journal. 16. 1 indexed citations
13.
Stenager, Egon & Kenneth B. Jensen. (2009). Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation. Acta Neurologica Scandinavica. 90(5). 305–308. 21 indexed citations
14.
O’Connor, P. & Egon Stenager. (2007). Safety of natalizumab upon re-dosing: Preliminary results from the STRATA study. Multiple Sclerosis Journal. 1 indexed citations
15.
Stenager, Egon, et al.. (2005). Multipel sklerose: udvikling i prævalens i Danmark 1950-1996 samt praevalens i amterne 1996. Ugeskrift for Læger. 167(14). 1 indexed citations
16.
Binzer, Michael, et al.. (2000). [Clinical, radiological, histopathological and genetic findings in a Danish "CADASIL" family].. PubMed. 162(12). 1739–42. 1 indexed citations
17.
Stenager, Egon, et al.. (1994). SEXUAL PROBLEMS IN MULTIPLE SCLEROSIS. International Journal of Adolescent Medicine and Health. 7(2). 95–106. 3 indexed citations
18.
Stenager, Egon, et al.. (1992). Smertesyndromer forbundet med dissemineret sklerose. Ugeskrift for Læger. 154(17). 1 indexed citations
19.
Stenager, Egon, et al.. (1989). Traditionel og alternativ behandling af sklerosepatienter. Ugeskrift for Læger. 151(50). 1 indexed citations
20.
Stenager, Egon, Peter Gerner‐Smidt, & Carsten Kock-Jensen. (1986). Ventriculostomy-related infections?an epidemiological study. Acta Neurochirurgica. 83(1-2). 20–23. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026